C
688089
vs
S
Shanghai Composite
Over the past 12 months, Cabio Biotech Wuhan Co Ltd has underperformed Shanghai Composite, delivering a return of -12% compared to the Shanghai Composite's +25% growth.
Stocks Performance
688089 vs Shanghai Composite
Performance Gap
688089 vs Shanghai Composite
Performance By Year
688089 vs Shanghai Composite
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
Cabio Biotech Wuhan Co Ltd
Glance View
Cabio Biotech Wuhan Co Ltd is a China-based company principally engaged in biotechnology business. The Company is mainly engaged in the research and development, production and sales of polyunsaturated fatty acids arachidonic acid (ARA), algal oil docosahexaenoic acid (DHA) and sialic acid (SA), and natural beta-carotene products. Its products are mainly used in infant formula food, dietary supplements, nutritional health food and formula food for special medical purposes. The Company integrates industrial strain-oriented optimization technology, fermentation fine control technology, and efficient separation, purification and preparation technology, and provides nutrient products and innovative solutions for customers in the global nutrition and health field through sustainable microbial synthesis and manufacturing methods. The Company mainly conducts its business in domestic and overseas markets.
